Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This study is to demonstrate the superiority of combination of eprosartan/HCTZ versus ramipril/HCTZ.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Solvay Pharmaceuticals
• Treatments: Eprosartan

Criteria

Inclusion Criteria:

• essential hypertension,

• diabetes type 2

Exclusion Criteria:

• severe cardiovascular disease,

• grade 3 hypertension,

• secondary hypertension,

• abnormal liver enzymes